Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
US5762937A · kind A · utility
10Cited by
3References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 28, 1994 |
| Grant date | Jun 9, 1998 |
| Priority date | — |
| Expiry date | Mar 28, 2014 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/042
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention pertains to the discovery of antigenic cross reactivity between a pancreatic 64K autoantigen and glutamic acid decarboxylase (GAD). Autoantibodies toward GAD were found to be associated with insulin dependent diabetes (IDD). More specifically, the invention pertains to the use of GAD for the diagnosis, prevention and treatment of insulin dependent diabetes (IDD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.